Omni Viscocanalostomy is a surgical procedure used to treat glaucoma, a group of eye conditions that can lead to optic nerve damage and vision loss. It is a minimally invasive technique designed to reduce intraocular pressure (IOP) by creating a new drainage pathway for aqueous humor, the fluid that fills the front part of the eye.
During an Omni Viscocanalostomy, a surgeon creates a small incision in the eye's trabecular meshwork, the drainage structure responsible for regulating the outflow of aqueous humor. Then, a high-viscosity viscoelastic substance, such as a cohesive ophthalmic viscosurgical device (OVD), is injected into the Schlemm's canal. This canal is a tiny channel located near the trabecular meshwork and is responsible for draining the aqueous humor.
The injected viscoelastic substance helps to dilate the Schlemm's canal, facilitating the outflow of aqueous humor. This procedure aims to bypass any damaged or blocked trabecular meshwork and restore the natural drainage system of the eye. By improving the flow of fluid, the intraocular pressure is reduced, thereby preventing damage to the optic nerve.
Omni Viscocanalostomy is considered a minimally invasive alternative to traditional glaucoma surgeries, such as trabeculectomy or tube shunt procedures. It offers potential advantages such as faster recovery time, reduced risk of complications, and lower reliance on post-operative medications.
It's important to note that medical information and techniques may evolve over time. Therefore, it's always best to consult with a qualified ophthalmologist or healthcare professional for the most up-to-date information on specific procedures like Omni Viscocanalostomy.